ישראל - עברית - Ministry of Health

vitamed pharmaceutical industries ltd - hydrogen peroxide - תמיסה - hydrogen peroxide 3 % - hydrogen peroxide - hydrogen peroxide - cleaning and disinfecting of wounds.

ישראל - עברית - Ministry of Health

גאמידור דיאגנוסטיקה בע"מ - מומחה - מיכשור לביצוע בדיקות גנטיות דיאגנוסטיות למחלות סק ר תורשתיות

ישראל - עברית - Ministry of Health

trupharm marketing 1985 ltd. - urea hydrogen peroxide - טיפות - urea hydrogen peroxide 5 % - hydrogen peroxide - hydrogen peroxide - an aid for the removal of hardened ear wax.

ישראל - עברית - Ministry of Health

איילקס ביוטק בע"מ - מומחה - בדיקה מולקולרית לזיהוי סרטן הערמונית

ישראל - עברית - Ministry of Health

ben shimon floris ltd, israel - hydrogen peroxide - תמיסה - hydrogen peroxide 3 %w/w - hydrogen peroxide

ישראל - עברית - Ministry of Health

amgen europe b.v. - talimogene laherparepvec - תמיסה להזרקה - talimogene laherparepvec 10^8 pfu / 1 ml - talimogene laherparepvec

ישראל - עברית - Ministry of Health

amgen europe b.v. - talimogene laherparepvec - תמיסה להזרקה - talimogene laherparepvec 10^6 pfu / 1 ml - talimogene laherparepvec

ישראל - עברית - Ministry of Health

amgen europe b.v. - filgrastim - תמיסה להזרקה - filgrastim 30 mu/ml - filgrastim - filgrastim - - reduction in the duration and severity of neutropenia in patients treated with highly myelosuppressive chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ).- reduction in the duration of neutropenia in patients undergoing high-dose cytotoxic chemotherapy followed by bone marrow transplantation. - in children or adults with severe congenital neutropenia cyclic neutropenia or idiopathic neutropenia a history of clinically important infections within the last 12 months and three documented episodes of neutropenia (with an anc< 5 x 1000000000) long-term administration of neupogen is indicated to increase neutrophil counts and to reduce infections. - neupogen is indicated for the mobilisation of autologous peripheral blood progenitor cells alone or following myelosuppressive chemotherapy and the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc).

ישראל - עברית - Ministry of Health

amgen europe b.v. - filgrastim - תמיסה להזרקה - filgrastim 48 mu / 0.5 ml - filgrastim - filgrastim - - reduction in the duration and severity of neutropenia in patients treated with highly myelosuppressive chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ).- reduction in the duration of neutropenia in patients undergoing high-dose cytotoxic chemotherapy followed by bone marrow transplantation. - in children or adults with severe congenital neutropenia cyclic neutropenia or idiopathic neutropenia a history of clinically important infections within the last 12 months and three documented episodes of neutropenia (with an anc< 5 x 1000000000) long-term administration of neupogen is indicated to increase neutrophil counts and to reduce infections. - neupogen is indicated for the mobilisation of autologous peripheral blood progenitor cells alone or following myelosuppressive chemotherapy and the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc).

ישראל - עברית - Ministry of Health

amgen europe b.v. - filgrastim - תמיסה להזרקה - filgrastim 30 mu / 0.5 ml - filgrastim - filgrastim - - reduction in the duration and severity of neutropenia in patients treated with highly myelosuppressive chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ).- reduction in the duration of neutropenia in patients undergoing high-dose cytotoxic chemotherapy followed by bone marrow transplantation. - in children or adults with severe congenital neutropenia cyclic neutropenia or idiopathic neutropenia a history of clinically important infections within the last 12 months and three documented episodes of neutropenia (with an anc< 5 x 1000000000) long-term administration of neupogen is indicated to increase neutrophil counts and to reduce infections. - neupogen is indicated for the mobilisation of autologous peripheral blood progenitor cells alone or following myelosuppressive chemotherapy and the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc).